TELA Bio, Inc.
TELA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001561921
In the last 90 days, TELA Bio, Inc. insiders filed 4 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $19.3M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $186.0K in total
- 4
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +9 vs. previous quarter
- 45
- 13F valueReported value at the end of Q2 2026
- $19.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding TELA, Q2 2026
No superinvestor reported holding TELA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by TELA Bio, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)4:30 PM ET | Sep 16-17 | 2 days | Capper Joseph HDirector | PPurchase | +75.0K | $1.18 | +$88.8K | +71.5%179.8K after | 2 lots |
| Sep 16, 2026 (view filing)6:46 PM ET | Sep 14-15 | 2 days | Capper Joseph HDirector | PPurchase | +75.0K | $1.05 | +$78.4K | +251.5%104.8K after | 2 lots |
| Aug 19, 2026 (view filing)4:10 PM ET | Aug 17 | 2 days | Getz Heather CChief Executive Officer | PPurchase | +12.5K | $0.6649 | +$8.31K | +2.4%532.5K after | |
| Aug 17, 2026 (view filing)4:32 PM ET | Aug 14 | 3 days | Getz Heather CChief Executive Officer | PPurchase | +15.0K | $0.6978 | +$10.5K | +3.0%520.0K after | |
| Nov 17, 2025 (view filing)4:26 PM ET | Nov 17 | Same day | Ew Healthcare Partners Fund 2, L.P. and 3 others10% Owner, Other: See Remarks | PPurchaseCommon Stock, par value $0.001 per share | +3.60M | $1.11 | +$4.00M | +87.7%7.71M after | |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Cuca RobertoCOO and CFO | PPurchase | +64.4K | $2.25 | +$145.0K | +70.9%155.4K after | |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Talmo PaulChief Technology Officer | PPurchase | +22.2K | $2.25 | +$50.0K | +32.3%91.1K after | |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Koblish AntonyChief Executive Officer | PPurchase | +88.9K | $2.25 | +$200.0K | +24.0%458.9K after | |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Firestone Gregory A.Chief Commercial Officer | PPurchase | +6.67K | $2.25 | +$15.0K | +13.2%57.3K after | |
| Jul 2, 2024 (view filing)4:54 PM ET | Jun 28-Jul 2 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −428.3K | $4.72 | −$2.02M | −15.1%2.41M after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in TELA Bio, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 7,714,709 | $5.79M | 2.28% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 5,894,114 | $4.42M | 0.27% | +750,000+14.6% | Added |
| Stonepine Capital Management, LLC | 2,662,427 | $2.00M | 1.52% | +45,175+1.7% | Added |
| Silverarc Capital Management, LLC | 2,137,201 | $1.60M | 0.18% | −122,111−5.4% | Reduced |
| Vanguard Capital Management LLC | 1,568,218 | $1.18M | 0.00% | +27,594+1.8% | Added |
| DAFNA Capital Management LLC | 1,441,029 | $1.08M | 0.21% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 1,375,042 | $1.03M | 0.82% | −43,286−3.1% | Reduced |
| Sio Capital Management, LLC | 636,300 | $477.2K | 0.08% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 457,734 | $343.3K | 0.08% | +80,796+21.4% | Added |
| Geode Capital Management, LLC | 389,223 | $292.0K | 0.00% | −65,836−14.5% | Reduced |